Yes, foreign manufacturers are subject to drug quality audits in Japan. The Pharmaceuticals and Medical Devices Agency (PMDA) conducts inspections to ensure compliance with Japanese Good Manufacturing Practice (GMP) standards. These audits are crucial for maintaining drug safety and efficacy, and are mandatory for market approval in Japan.